Related Experiment Video
Updated: Jan 22, 2026

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.8K
Melanoma
Conor H O'Neill1, Charles R Scoggins1
1Hiram C. Polk, JR, MD Department of Surgery, Division of Surgical Oncology, University of Louisville, Louisville, Kentucky.
Journal of Surgical Oncology
|June 28, 2019
Summary
Current guidelines do not recommend skin cancer screening. However, new technologies may support visual inspection for melanoma detection in high-risk individuals.
Area of Science:
- Dermatology
- Oncology
- Preventive Medicine
Background:
- Current United States Preventive Services Task Force recommendations do not support general skin cancer screening.
- Melanoma detection relies on visual inspection, presenting a unique challenge for screening.
- Technological advancements are emerging to aid in the visual detection of skin cancer.
Purpose of the Study:
- To evaluate the role of emerging technologies in skin cancer screening.
- To identify high-risk populations that may benefit from enhanced visual inspection for melanoma.
- To inform future screening paradigms for melanoma detection.
Main Methods:
- Review of current screening recommendations and technological developments.
- Analysis of melanoma detection methods, emphasizing visual inspection.
- Identification of demographic and historical factors defining high-risk populations.
Main Results:
- Despite current recommendations against screening, melanoma's visual detectability offers potential for targeted approaches.
- Technologies aiding visual inspection show promise for screening in specific high-risk groups.
- Older, fair-skinned males with a personal or family history of melanoma represent a key high-risk demographic.
Conclusions:
- Future skin cancer screening strategies may involve targeted approaches using new technologies.
- Defining specific high-risk populations is crucial for the effective implementation of these technologies.
- Further research is needed to integrate these advancements into clinical practice for melanoma prevention.

